Curt-Erik Hagberg

Title: Curt-Erik Hagberg: Innovator in Antiviral Compounds

Introduction

Curt-Erik Hagberg is a notable inventor based in Upplands Vasby, Sweden. He has made significant contributions to the field of antiviral research, particularly in the development of novel compounds aimed at combating herpes virus infections. His work has the potential to impact the pharmaceutical industry and improve treatment options for patients.

Latest Patents

Hagberg holds a patent for "Derivatives of guanine for combating herpes virus infections." This patent describes novel antiviral compounds characterized by a specific formula, wherein each of R1 and R2 can be hydrogen, hydroxy, or fluoro. The patent also outlines methods for the preparation of these compounds, pharmaceutical preparations containing them, and methods for treating virus infections and other diseases caused by viruses. He has 1 patent to his name.

Career Highlights

Curt-Erik Hagberg has been associated with Astra Lakemedel Aktiebolag, where he has contributed to various research initiatives. His work in the field of antiviral compounds showcases his dedication to advancing medical science and improving public health.

Collaborations

Hagberg has collaborated with notable colleagues, including Karl N Johansson and Zsuzsanna M Kovacs. These partnerships have likely enhanced the scope and impact of his research efforts.

Conclusion

Curt-Erik Hagberg's innovative work in antiviral compounds represents a significant advancement in the fight against viral infections. His contributions to the field are commendable and highlight the importance of research in developing effective treatments.